Remdesivir and chloroquine effectively inhibit SARS-CoV-2

Featured

• 

  Identification of an endogenous glutamatergic transmitter system controlling excitability and conductivity of atrial cardiomyocytes

  • Duanyang Xie
  • Ke Xiong
  • Yi-Han Chen

  Article Open Access 06 Apr 2021
• 

  In vivo self-assembled small RNAs as a new generation of RNAi therapeutics

  • Zheng Fu
  • Xiang Zhang
  • Xi Chen

  Article Open Access 29 Mar 2021
• 

  Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2

  • Renhong Yan
  • Yuanyuan Zhang
  • Qiang Zhou

  Letter Open Access 18 Mar 2021

Current issue

• Remembering past infections: training exercise for gut microbes

  • Samuel Philip Nobs
  • Eran Elinav

  Research Highlight 23 Feb 2021

• Young haematopoietic stem cells are picky eaters

  • Nick van Gastel
  • David T. Scadden

  Research Highlight 25 Feb 2021

• TDP-43 triggers immune response via mitochondrial DNA release

  • Sunny Kumar
  • Jean-Pierre Julien

  Research Highlight 18 Feb 2021

• Structural mechanism of cooperative activation of the human calcium-sensing receptor by Ca²⁺ ions and L-tryptophan

  • Shenglong Ling
  • Pan Shi
  • Changlin Tian

  Article Open Access 18 Feb 2021

• Coinfection with influenza A virus enhances SARS-CoV-2 infectivity

  • Lei Bai
  • Yongliang Zhao
  • Ke Xu

  Article Open Access 18 Feb 2021

• The m⁶A methylome of SARS-CoV-2 in host cells

  • Jun’e Liu
  • Yan-Peng Xu
  • Cheng-Feng Qin

  Article Open Access 28 Jan 2021

Contents

View all issues

• Center for Excellence in Molecular Cell Science

  

• SharedIt

  

• Guide to Authors

  

• Research Data

  

Advertisement

Browse articles

• 

  Intestinal tête-à-tête: helminths blunt immunity against flaviviruses

  • David E. Place
  • Thirumala-Devi Kanneganti

  Research Highlight 12 Apr 2021
• 

  A new molecular target for antidepressants

  • Sarah Ateaque
  • Yves-Alain Barde

  Research Highlight 06 Apr 2021
• 

  Identification of an endogenous glutamatergic transmitter system controlling excitability and conductivity of atrial cardiomyocytes

  • Duanyang Xie
  • Ke Xiong
  • Yi-Han Chen

  Article Open Access 06 Apr 2021
• 

  Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms

  • Yao Sun
  • Lei Wang
  • Xiangxi Wang

  Letter Open Access 29 Mar 2021
• 

  In vivo self-assembled small RNAs as a new generation of RNAi therapeutics

  • Zheng Fu
  • Xiang Zhang
  • Xi Chen

  Article Open Access 29 Mar 2021
• 

  Double insult: flu bug enhances SARS-CoV-2 infectivity

  • Shan Su
  • Zezhong Liu
  • Shibo Jiang

  Research Highlight 23 Mar 2021
• 

  SARS-CoV-2 spike protein interacts with and activates TLR41

  • Yingchi Zhao
  • Ming Kuang
  • Fuping You

  Letter to the Editor 19 Mar 2021
• 

  Molecular basis of ligand recognition and activation of human V2 vasopressin receptor

  • Fulai Zhou
  • Chenyu Ye
  • Yi Jiang

  Letter to the Editor 19 Mar 2021
• 

  Self-made allostery: endogenous COMP antagonizes pathologic AT1_AR signaling

  • Ama Dedo Okyere
  • Douglas G. Tilley

  Research Highlight 18 Mar 2021

Collections

A special collection of reviews on frontiers in immunology

Chenqi Xu, Hua-Bing Li and Richard A. Flavell presented a special review collection in Cell Research discussing our understanding and perspectives of immunological frontiers. The review collection covered diverse topics including cancer immunology, immunometabolism, regulatory T cells, innate lymphoid cells, microbiota/immune interplay, and the inflammasome.

Focus 17 Sept 2020

Trending - Altmetric

• 

  Coinfection with influenza A virus enhances SARS-CoV-2 infectivity

• 

  Interaction between microbiota and immunity in health and disease

• 

  Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma

• 

  Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

• 

  This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

•